Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,895,256 papers from all fields of science
Search
Sign In
Create Free Account
BI 397
Known as:
BI397
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Teicoplanin
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
16S rRNA methylase gene, together with quinolone resistance determinant aac(6')-Ib-cr, in a Serratia marcescens isolate from China.
Hai-fei Yang
,
Jun Cheng
,
+5 authors
Jiabin Li
Diagnostic microbiology and infectious disease
2013
Corpus ID: 38378824
Highly Cited
2012
Highly Cited
2012
Glycopeptide Antibiotics
F. Bambeke
,
Y. Laethem
,
P. Courvalin
,
P. Tulkens
Drugs
2012
Corpus ID: 46959404
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. Emergence of resistance in…
Expand
Review
2006
Review
2006
Dalbavancin: a review for dermatologists.
N. Scheinfeld
Dermatology Online Journal
2006
Corpus ID: 31333777
Most complicated skin and skin structure infections (cSSSI) are caused by Staphylococcus aurens (SA) and streptococcus (SC). More…
Expand
2005
2005
Meningitis Due to Vancomycin-Resistant Enterococcus faecium Successfully Treated with Combined Intravenous and Intraventricular Chloramphenicol
P. Scapellato
,
C. Ormazabal
,
J. Scapellato
,
E. Bottaro
Journal of Clinical Microbiology
2005
Corpus ID: 37749243
We report a case of meningitis caused by vancomycin-resistant Enterococcus faecium (VREF) that was succesfully treated with…
Expand
Review
2004
Review
2004
Glycopeptide antibiotics: from conventional molecules to new derivatives.
F. Van Bambeke
,
Y. Van Laethem
,
P. Courvalin
,
P. Tulkens
Drugs
2004
Corpus ID: 10380
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. Emergence of resistance in…
Expand
2004
2004
Evaluations of Dalbavancin Activity and Spectrum Tested Against European Isolates
R. Jones
,
T. Fritsche
,
H. Sader
,
J. Streit
2004
Corpus ID: 86339626
Background: Ongoing development of novel resistances (R) and the increased frequency of currently characterized R, requires the…
Expand
2003
2003
Initial Quality Control Evaluations for Susceptibility Testing of Dalbavancin (BI397), an Investigational Glycopeptide with Potent Gram-Positive Activity
T. Anderegg
,
D. Biedenbach
,
Ronald N. Jones
Journal of Clinical Microbiology
2003
Corpus ID: 39160106
As gram-positive pathogens have acquired resistances to traditional therapeutic agents and multidrug-resistant clones have spread…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE